Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    88,643.01
    +1,464.70 (+1.68%)
     

  • CMC Crypto 200

    1,384.91
    +72.28 (+5.50%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Agios Pharmaceuticals

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / December 12, 2018 / U.S. equities finished lower on Tuesday after bouncing between the red and green territory. The stocks gained more than 1% across the board on improving U.S.-China trade relations. Bloomberg news reported that China plans on cutting down tariffs on cars made in U.S., from the current 40% to 15%. However, stocks started moving in the opposite direction on the news of a contentious fight between President Donald Trump and Democratic leadership over border security. President Trump’s threat to shut down the government weighed on the markets. The Dow Jones Industrial Average dropped 0.22 percent to close at 24,370.24, while the S&P 500 Index decreased 0.04 percent to close at 2,636.78. The Nasdaq Composite Index gained 0.16 percent to close at 7,031.83.

According to the Chief Market Strategist of Prudential Financial, Quincy Crosby, "It is important for the market to get positive headlines at this time. The algorithms work instantaneously and if we get someone with an opposing view we could turn around."

The Market Edge Initiates Coverage on:

Arrowhead Pharmaceuticals, Inc.
https://marketedgereport.com/report/ARWR/

ADVERTISEMENT

Agios Pharmaceuticals, Inc.
https://marketedgereport.com/report/AGIO/

Arrowhead Pharmaceuticals' stock moved 0.29% lower Tuesday, to close the day at $13.62. The stock recorded a trading volume of 1,078,517 shares, which was below its three months average volume of 2,592,463 shares. In the last year, Arrowhead Pharmaceuticals' shares have traded in a range of 3.01 - 22.39. The share price has gained 352.49% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $16.64 is above its 200-day moving average of $13.27. Shares of Arrowhead Pharmaceuticals have fallen roughly 6 percent in the past month and are up 270.11 percent year-to-date.

Access The Market Edge's Arrowhead Pharmaceuticals, Inc. ResearchReport:
https://marketedgereport.com/report/ARWR/

On Tuesday, shares of Agios Pharmaceuticals recorded a trading volume of 931,379 shares, which was above the three months average volume of 531,325 shares. The stock ended the day 3.43% higher at $54.53. The share price has fallen 45.37% from its 52 week high with a 52 week trading range of 50.96 - 99.82. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $64.04 is below its 200-day moving average of $77.30. Shares of Agios Pharmaceuticals have fallen roughly 21.07 percent in the past month and are down 4.62 percent year-to-date.

Access The Market Edge's Agios Pharmaceuticals, Inc. Research Report:
https://marketedgereport.com/report/AGIO/

Our Actionable Research on Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: The Market Edge